{"database": "lobbying", "table": "lobbying_activities", "rows": [[2139612, "be6efb95-2d1b-4267-84fb-5511669a1994", "Q2", "CEPI-U.S.", 401104645, "CEPI-U.S.", 2018, "second_quarter", "HCR", "Appropriations for CEPI Norway, Pandemics and All-Hazards Preparedness Reauthorization, possible addition of MERS/Lassa/Nipah to FDA's Priority Review Voucher program.", "Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Security Council (NSC),Office of Management & Budget (OMB),SENATE,U.S. Agency for International Development (USAID)", 7000, null, 0, 0, "2018-06-29T18:35:08.883000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2139612"], "units": {}, "query_ms": 0.29715802520513535, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}